ГоловнаArchive of numbers2014Volume 22 , issue 4 (81)Correction of cognitive impairments in patients with chronic brain ischemia
Title of the article Correction of cognitive impairments in patients with chronic brain ischemia
Authors Statinova Olena Anatoliivna
Mamedaliieva Sevindzh
Seleznova Sofia
In the section HELP TO PRACTICAL PHYSICIAN
Year 2014 Issue Volume 22 , issue 4 (81) Pages 134-136
Type of article Scientific article Index UDK 616.831-005.4:159.922-08 Index BBK -
Abstract The article is devoted to the application of the derived exogenous choline alfoscerate (gliatilin), as a neuro protector for the correction of cognitive impairment in patients with chronic ischemia of the brain. Cognitive impairment in patients with chronic ischemia of the brain are characterized by impairments in all areas of cognitive activity: modalitynonspecifi c memory disorders, thinking disorders, speed of information processing, executive functions associated with structural changes in frontal, parietal and limbic areas. The article presents evidence in favor of the eff ectiveness of choline alfoscerate in neurodegenerative disorders characterized by a reduction in cholinergic neurotransmission. It is shown that the purpose of gliatilin patients with cognitive impairment at a dose of 1000 mg/m 1 time per day for 14 days, then 400 mg 2 times a day for 2 months significantly improves cognitive function, improves mental performance.
Key words chronic ischemia of the brain, cognitive impairment, choline alfoscerate.
Access to full text version of the article pdf download
Bibliography